Boehringer Ingelheim Caps Patient Out-of-pocket Inhaler Costs at $35 per Month
Starting June 1, 2024, eligible patients will pay no more than $35 a month at retail pharmacies for all Boehringer Ingelheim inhalers, the company says.
Tag: aerosol therapy delivery
All
Latest
All
Latest
FDA Approves Airsupra Asthma Rescue Inhaler
AstraZeneca's Airsupra is the first FDA-approved combination of an inhaled corticosteroid and a short-acting beta-agonist for prevention of asthma exacerbations.
All
Latest
Switching to Dry Powder Inhaler Cuts Carbon Footprint of Asthma Medication Delivery
Researchers say the hydrofluorocarbons in pressurized metered dose inhalers are potent greenhouse gases and switching to dry powder inhalers would cut emissions while not worsening asthma management.
Patients with Severe Asthma Rarely Switch Biologics
Asthma patients in the US who use biologic therapies don’t often switch from one biologic therapy to another, according to data from a recent study.
Read More
Who Invented the Asthma Inhaler?
A report from Smithsonian Magazine explores the origin story of the asthma inhaler.
Read More
Electronic Alert Reduces Excessive Prescribing of Short-acting Asthma Relievers
An automatic, electronic alert on general practitioners’ computer screens can help to prevent excessive prescribing of short-acting asthma reliever medication, according to research presented at the virtual European Respiratory Society International Congress.
Read More
Outcomes in Newly Diagnosed Asthma Patients
Response to inhaled corticosteroids in individuals with newly diagnosed asthma may be predicted by high blood and sputum eosinophil counts, according to a new study.
Read More
Is Single-inhaler Therapy The Right Approach For COPD Patients?
A new study shows that chronic obstructive pulmonary disease (COPD) patients may experience the strongest benefits from single-inhaler therapy.
Read More
Is COVID-19 Driving Medication Adherence for Asthma, COPD Patients?
Researchers believe the COVID-19 pandemic may have influenced increases in medication adherence for patients with asthma and COPD between January and March 2020.
Read More
A New Understanding of Asthma Medicines
Research into common asthma aerosol treatments could improve therapeutics in the future, according to a study published in European Journal of Pharmaceutics and Biopharmaceutics.
Read More
First Generic Proventil HFA Albuterol Inhaler Approved
The US FDA has approved the first generic metered dose inhaler of Proventil HFA (albuterol sulfate), manufactured by Cipla Ltd.
Read More
Asthma Patients Advised to Stay on Steroids During Coronavirus Outbreak
Asthma specialists are suggesting that patients keep using their preventive inhalers during the coronavirus pandemic, despite an increase in demand.
Read More
Albuterol Shortage Looms During Coronavirus Pandemic
As the number of COVID-19 cases grow, hospitals throughout the US are reporting shortages of albuterol, a life saving medication for asthma sufferers.
Read More
Combination Inhaler Therapy Decreases COPD Deaths
A once-daily inhaler combination of fluticasone furoate, umeclidinium and vilanterol reduced overall mortality in patients with chronic obstructive pulmonary disease (COPD) by 42%.
Read More
Young Adults Not Sticking to Their ICS Asthma Therapy
Nearly 3-in-4 of emerging adults with asthma do not adhere to their prescribed inhaled corticosteroid therapy, according to a study published in the Journal of Asthma.
Read More